SGN-B6A
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Integrin
Related Pathways
Cytoskeletal Signaling, Antibody-drug Conjugate/ADC Related
Bioactivity
SGN-B6A is an ADC (antibody-drug conjugate) that targets integrin β-6 (ITGB6) using the human IgG1 monoclonal antibody Sigvotatug, and exhibits cytotoxicity towards various integrin β-6 positive cancer cells through the mitosis inhibitor MMAE.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
218877-01 20 µL
CLEC12A (CLL1, MICL, CLL-1, DCAL-2, C-type Lectin Domain Family 12 Member A) discontinued
Sign In for Pricing
View Details